Concepedia

Helena Nissinen

HN

6

Publications

635

Citations

6

H-Index

2004

Active since

Affiliations

Orion Corporation (Finland)(Current)

Kista Photonics Research Center

University of Turku

The Royal Free Hospital

National Hospital for Neurology and Neurosurgery

Helena Nissinen is an author at Orion Corporation (Finland) specializing in medicine, movement disorders, and pharmacotherapy.

Top concepts

Publications per year

2004–2015

6

Publications

6

Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease

C. Warren Olanow, Karl Kieburtz, Olivier Rascol et al. · Movement Disorders · 2013 · 455 citations

, , +13

Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis

Juhani Ruutiainen, Anna-Mari Viita, Jarmo Hahl et al. · Journal of Medical Economics · 2015 · 45 citations

The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats

Erkki Nissinen, Helena Nissinen, H. Larjonmaa et al. · Journal of Neural Transmission · 2004 · 40 citations

, , +5

Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson’s disease

David J. Brooks, Mika Leinonen, Mikko Kuoppamäki et al. · Journal of Neural Transmission · 2008 · 33 citations

, , +8

Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis

Helena Nissinen, Mikko Kuoppamäki, M. Leinonen et al. · European Journal of Neurology · 2009 · 32 citations · Full text

Rows per page

1–5 of 6